Patients who have had surgery to create a Fontan circulation show changes in their genetic code, which may provide a new treatment opportunity to reduce premature aging. The procedure is used to treat ...
Patients with Fontan circulatory failure face higher mortality risk while awaiting or after undergoing heart transplantation, if they have certain health complications, according to a multi-center ...
Hosted on MSN
Analysis shows udenafil significantly improves exercise capacity in Fontan patients with reduced baseline function
A newly published, post-hoc analysis of the landmark FUEL (Fontan Udenafil Exercise Longitudinal) Trial demonstrates that udenafil, a PDE5 inhibitor, significantly improves peak oxygen consumption ...
SEOUL, South Korea, July 31, 2025 /PRNewswire/ -- Mezzion Pharmaceuticals, Inc. (Mezzion) announced that its confirmatory Phase 3 FUEL-2 study evaluating JURVIGO® (udenafil)1 in adolescents and young ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback